HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yanjun Zheng Selected Research

Neoplasms (Cancer)

2/2022A highly selective and sensitive chemiluminescent probe for leucine aminopeptidase detection in vitro, in vivo and in human liver cancer tissue.
2/2022Photothermal scaffolds/surfaces for regulation of cell behaviors.
1/2021Optimization of CAR-T Cell-Based Therapies Using Small-Molecule-Based Safety Switches.
10/2018Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma.
1/2016Linearly Patterned Programmed Cell Necrosis Induced by Chronic Hypoxia Plays a Role in Melanoma Angiogenesis.
1/2016Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype.
3/2011Eupatilin Inhibits Gastric Cancer Cell Growth by Blocking STAT3-Mediated VEGF Expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yanjun Zheng Research Topics

Disease

7Neoplasms (Cancer)
02/2022 - 03/2011
5Infarction (Infarctions)
04/2022 - 02/2015
3Hypoxia (Hypoxemia)
08/2019 - 03/2011
2Insulin Resistance
11/2021 - 01/2017
2Reperfusion Injury
11/2020 - 01/2017
2Myocardial Ischemia (Ischemic Heart Diseases)
11/2020 - 08/2019
2Ischemia
01/2020 - 01/2017
1Liver Neoplasms (Liver Cancer)
02/2022
1Inflammation (Inflammations)
01/2022
1Glioma (Gliomas)
01/2022
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2021
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2021
1Sepsis (Septicemia)
01/2021
1Moyamoya Disease (Moya-Moya Disease)
01/2020
1Breast Neoplasms (Breast Cancer)
01/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020
1Carcinoma (Carcinomatosis)
01/2020
1Hepatocellular Carcinoma (Hepatoma)
10/2018
1Neoplasm Metastasis (Metastasis)
10/2018
1Non-alcoholic Fatty Liver Disease
01/2018
1Thyroid Diseases (Thyroid Disease)
12/2017
1Type 2 Diabetes Mellitus (MODY)
01/2017
1Hemorrhage
11/2016
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2014
1Stomach Neoplasms (Stomach Cancer)
03/2011

Drug/Important Bio-Agent (IBA)

3Long Noncoding RNAIBA
01/2021 - 10/2018
2Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2020
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2018
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2020 - 02/2015
2Proteins (Proteins, Gene)FDA Link
01/2016 - 01/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 03/2011
1RNA (Ribonucleic Acid)IBA
04/2022
1Tumor Biomarkers (Tumor Markers)IBA
02/2022
1Leucyl Aminopeptidase (Peptidase S)IBA
02/2022
1Pharmaceutical PreparationsIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Follicle Stimulating Hormone (Follitropin)FDA Link
11/2021
1Dehydroepiandrosterone SulfateIBA
11/2021
1ProgesteroneFDA LinkGeneric
11/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1AndrogensIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Mechanistic Target of Rapamycin Complex 1IBA
11/2020
1purineIBA
01/2020
1pinocembrinIBA
01/2020
1Competitive Endogenous RNAIBA
01/2020
1Circular RNAIBA
08/2019
1Small Interfering RNA (siRNA)IBA
10/2018
1iodized salt (iodised salt)IBA
12/2017
1IodineIBA
12/2017
1hydroxide ionIBA
01/2017
1berbamine (penduline)IBA
01/2017
1Vitamin DFDA LinkGeneric
01/2017
1Polypropylenes (Polypropylene)IBA
11/2016
1NestinIBA
01/2016
1VimentinIBA
01/2016
1cadherin 5IBA
01/2016
1Cadherins (E-Cadherin)IBA
01/2016
1CaspasesIBA
01/2016
1CateninsIBA
01/2016
1CalciumIBA
01/2016
1ChromatinIBA
03/2011
1eupatilinIBA
03/2011
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
03/2011
1Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA
03/2011

Therapy/Procedure

2Therapeutics
02/2022 - 01/2022
2Immunotherapy
01/2022 - 01/2021
1Ligation
01/2021
1Punctures
01/2021
1Operative Time
11/2016
1Sutures (Suture)
11/2016